Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experience.
Droz
J P
JP
Department of Medicine, Institut Gustave-Roussy, Villejuif/France.
Azab
M B
MB
Theodore
C
C
Ghosn
M
M
Ostronoff
M
M
Boutan-Laroze
A
A
Court
B H
BH
Perrin
J L
JL
Travagli
J P
JP
Wibault
P
P
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D015653:Cystectomy; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*; D014747:Vinblastine / Q000008:administration & dosage
D014747:Vinblastine; D002945:Cisplatin; D008727:Methotrexate